Skip to main content
. 2017 Nov 3;17(1):835–842. doi: 10.3892/mmr.2017.7955

Figure 4.

Figure 4.

Detection of antibodies to TRIM28 in the sera of NSCLC patients (n=138) and healthy patient (n=80) determined by reverse ELISA. Seropositivity in NSCLC patients was considered the cases in which an absorbance was greater than the mean control absorbance ± 2 SD. NSCLC, non-small cell lung cancer; ELISA, enzyme-linked immunosorbent assay; SD, standard deviation.